BRPI0209720A2 - dosagem e embalagem de medicação com liberação controlada - Google Patents

dosagem e embalagem de medicação com liberação controlada

Info

Publication number
BRPI0209720A2
BRPI0209720A2 BRPI0209720A BRPI0209720A BRPI0209720A2 BR PI0209720 A2 BRPI0209720 A2 BR PI0209720A2 BR PI0209720 A BRPI0209720 A BR PI0209720A BR PI0209720 A BRPI0209720 A BR PI0209720A BR PI0209720 A2 BRPI0209720 A2 BR PI0209720A2
Authority
BR
Brazil
Prior art keywords
dosage
packaging
controlled release
release medication
medication
Prior art date
Application number
BRPI0209720A
Other languages
English (en)
Inventor
V Gumaste Anand
L Abrams Andrew
Original Assignee
Microdose Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Tech Inc filed Critical Microdose Tech Inc
Publication of BRPI0209720A2 publication Critical patent/BRPI0209720A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
BRPI0209720A 2001-05-31 2002-05-22 dosagem e embalagem de medicação com liberação controlada BRPI0209720A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
PCT/US2002/016185 WO2002096347A2 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication

Publications (1)

Publication Number Publication Date
BRPI0209720A2 true BRPI0209720A2 (pt) 2017-06-13

Family

ID=23134944

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209720A BRPI0209720A2 (pt) 2001-05-31 2002-05-22 dosagem e embalagem de medicação com liberação controlada

Country Status (8)

Country Link
EP (1) EP1408907A4 (pt)
JP (1) JP2005514966A (pt)
AU (1) AU2002303840A1 (pt)
BR (1) BRPI0209720A2 (pt)
CA (3) CA2614902A1 (pt)
NZ (1) NZ529696A (pt)
WO (1) WO2002096347A2 (pt)
ZA (1) ZA200402466B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
TWI336260B (en) * 2002-07-25 2011-01-21 Glaxo Group Ltd Dosage form suitable for retaining drug substance
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
CA2625776A1 (en) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Pharmaceutical packaging of an oral dosage combination
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CN104382598A (zh) 2008-08-13 2015-03-04 普罗透斯数字保健公司 一种产生识别器的方法
NZ596292A (en) 2009-04-28 2014-04-30 Proteus Digital Health Inc Highly reliable ingestible event markers and methods for using the same
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
EP2555737A4 (en) 2010-04-07 2013-09-18 Proteus Digital Health Inc FORMABLE MINIATURE DEVICE
JP2014504902A (ja) * 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド 医薬品を有する摂取可能なデバイス
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
AU2013293234B2 (en) 2012-07-23 2017-08-31 Otsuka Pharmaceutical Co., Ltd. Techniques for manufacturing ingestible event markers comprising an ingestible component
DK2910013T3 (en) 2012-10-18 2018-08-06 Proteus Digital Health Inc Apparatus, system and method for adaptive optimization for power output and transmit power in a power source for a communication device
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
MX2019000888A (es) 2016-07-22 2019-06-03 Proteus Digital Health Inc Percepcion y deteccion electromagnetica de marcadores de evento ingeribles.
TWI735689B (zh) 2016-10-26 2021-08-11 日商大塚製藥股份有限公司 製造含有可攝食性事件標記之膠囊之方法
TW202126301A (zh) 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication

Also Published As

Publication number Publication date
ZA200402466B (en) 2006-07-26
AU2002303840A1 (en) 2002-12-09
WO2002096347A3 (en) 2003-03-27
CA2614902A1 (en) 2002-12-05
CA2614899A1 (en) 2002-12-05
EP1408907A4 (en) 2010-02-24
EP1408907A2 (en) 2004-04-21
CA2448997A1 (en) 2002-12-05
NZ529696A (en) 2008-07-31
JP2005514966A (ja) 2005-05-26
WO2002096347A2 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
EP1408907A4 (en) DOSAGE AND PACKAGING OF CONTROLLED RELEASE DRUGS
HRP20030873A2 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylatoe having such element
NO20030627L (no) Hydrogel-drevet medikament doseringsform
DE60115418D1 (de) Mikroinfusionsvorrichtung zur verabreichung von medikamenten
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
GB0117618D0 (en) Pharmaceutical dosage form
NO20033384L (no) Farmasoytisk formulering
GB0117619D0 (en) Pharmaceutical dosage form
DE60225014D1 (de) Pharmazeutische zusammensetzungen von amlodipin und atorvastatin
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
NO20035627D0 (no) Farmasöytisk formulering
EP1299337A4 (en) HYDROXYPHENSTATIN AND ITS PROMEDICATIONS
DE60211183D1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
EP1501352A4 (en) METHOD AND COMPOSITIONS FOR PROTRACTED ACTIVE SUBSTANCE
ITBO20010005V0 (it) Distributore automatico di medicinali
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE60214533D1 (de) Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
UA4167S (uk) Набір упаковок для ліків «метрозол»
UA4854S (uk) Упаковка медичного препарату

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI